These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37261631)

  • 1. Beijing Children's Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma.
    Yang W; Ma W; Huang J; Cai Y; Peng X; Zhao F; Zhang D; Zou Z; Sun H; Qi X; Ge M
    Metab Brain Dis; 2023 Oct; 38(7):2393-2400. PubMed ID: 37261631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the prognostic factors in medulloblastoma of children and adults.
    Brandes AA; Paris MK
    Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
    Amlashi SF; Riffaud L; Brassier G; Morandi X
    Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
    Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
    Syst Rev; 2020 Mar; 9(1):47. PubMed ID: 32127049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
    Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
    BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood Medulloblastoma: An Overview.
    Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
    Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medulloblastoma].
    Bouffet E; Frappaz D; Carrie C; Freycon F; Brunat-Mentigny M
    Pediatrie; 1991; 46(1):71-8. PubMed ID: 1851287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood medulloblastoma: progress and future challenges.
    Packer RJ
    Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
    Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
    Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding medulloblastoma.
    Quinlan A; Rizzolo D
    JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
    Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
    Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
    Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
    Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
    Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
    Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current multimodality management of medulloblastoma.
    Paulino AC
    Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.